- Home
- TRVI vs SMC Comparison
TRVI vs SMC Comparison
Compare TRVI & SMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- SMC
- Stock Information
- Founded
- TRVI 2011
- SMC 2009
- Country
- TRVI United States
- SMC United States
- Employees
- TRVI N/A
- SMC N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- SMC
- Sector
- TRVI Health Care
- SMC
- Exchange
- TRVI Nasdaq
- SMC NYSE
- Market Cap
- TRVI 341.4M
- SMC 402.7M
- IPO Year
- TRVI 2019
- SMC 2012
- Fundamental
- Price
- TRVI $3.76
- SMC $41.45
- Analyst Decision
- TRVI Strong Buy
- SMC
- Analyst Count
- TRVI 8
- SMC 0
- Target Price
- TRVI $9.31
- SMC N/A
- AVG Volume (30 Days)
- TRVI 659.4K
- SMC 74.5K
- Earning Date
- TRVI 11-06-2024
- SMC 02-05-2025
- Dividend Yield
- TRVI N/A
- SMC N/A
- EPS Growth
- TRVI N/A
- SMC N/A
- EPS
- TRVI N/A
- SMC N/A
- Revenue
- TRVI N/A
- SMC $450,857,000.00
- Revenue This Year
- TRVI N/A
- SMC N/A
- Revenue Next Year
- TRVI N/A
- SMC N/A
- P/E Ratio
- TRVI N/A
- SMC N/A
- Revenue Growth
- TRVI N/A
- SMC 7.80
- 52 Week Low
- TRVI $1.27
- SMC $15.56
- 52 Week High
- TRVI $4.68
- SMC $42.26
- Technical
- Relative Strength Index (RSI)
- TRVI 48.03
- SMC 80.89
- Support Level
- TRVI $3.63
- SMC $37.79
- Resistance Level
- TRVI $4.06
- SMC $38.03
- Average True Range (ATR)
- TRVI 0.30
- SMC 1.06
- MACD
- TRVI -0.09
- SMC 0.32
- Stochastic Oscillator
- TRVI 12.21
- SMC 87.68
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, primarily shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.